Sat, Aug 23, 2014, 5:42 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

DreamWorks Animation SKG Inc. Message Board

jaw02 1 post  |  Last Activity: Aug 19, 2014 4:32 PM Member since: Mar 20, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Anyone have info on this news break?

    by an41466 Aug 19, 2014 4:20 PM
    jaw02 jaw02 Aug 19, 2014 4:32 PM Flag

    It is the patent. Here is the press release:

    Achillion Granted U.S. Patent for ACH-3102 and Structurally Related NS5A Inhibitors

    NEW HAVEN, Conn., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. Patent No. 8,809,313, covering composition-of-matter and method of use claims for ACH-3102 and structurally related NS5A inhibitor compounds.

    ACH-3102 is Achillion's second generation Phase 2 NS5A inhibitor being investigated for the treatment of chronic hepatitis C virus (HCV) infection.

    This patent is entitled "Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections," and provides a patent term which lasts until 2032.

    Sentiment: Buy

DWA
21.93+0.08(+0.37%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.